✦ LIBER ✦

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

✍ Scribed by R. M. Zuniga; R. Torcuator; R. Jain; J. Anderson; T. Doyle; S. Ellika; L. Schultz; T. Mikkelsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II trial and pharmacokinetic s

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

NCI-Sponsored Trial for the Evaluation o

✍ Alexander M. Spence; Mark Muzi; Jeanne M. Link; John M. Hoffman; Janet F. Eary; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 364 KB

Erratum to: A phase I/II trial and pharm

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

A phase 2 trial of single-agent bevacizu

✍ Jeffrey J. Raizer; Sean Grimm; Marc C. Chamberlain; M. Kelly Nicholas; James P. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 1 views

A phase II study of O6-benzylguanine and

✍ Katherine E. Warren; Sri Gururangan; J. Russell Geyer; Roger E. McLendon; Tina Y 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 225 KB

NCI-Sponsored Trial for the Evaluation o

✍ Alexander M. Spence; Mark Muzi; Jeanne M. Link; Finbarr O’Sullivan; Janet F. Ear 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 476 KB